U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6702167021A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the KneeTerminatedHas ResultsCartilage Injury of KneeDrug: Sprifermin (AS902330)|Drug: Sprifermin (AS902330)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01689337
6702267022Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCompletedHas ResultsPertussis|Tetanus|DiphtheriaBiological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussishttps://ClinicalTrials.gov/show/NCT01689324
6702367023In Vitro Myometrial Contractions in Laboring and Non-laboring WomenCompletedNo Results AvailablePostpartum HemorrhageDrug: Oxytocin|Drug: Ergonovine|Drug: Prostaglandin F2alpha|Drug: Misoprostolhttps://ClinicalTrials.gov/show/NCT01689311
6702467024Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatmentCompletedNo Results AvailablePostpartum HemorrhageDrug: Oxytocin|Drug: Carbetocinhttps://ClinicalTrials.gov/show/NCT01689298
6702567025Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNo Results AvailableVaricella Zoster Virus Infection|Herpes Simplex Virus InfectionDrug: valacyclovir tablet|Drug: valacyclovir oral solutionhttps://ClinicalTrials.gov/show/NCT01689285
6702667026Functional Reserve Estimation of Donor KidneyCompletedNo Results AvailableEnd-stage Renal DiseaseProcedure: Kidney Transplantation from alive relative donorhttps://ClinicalTrials.gov/show/NCT01689272
6702767027Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy AdultsCompletedNo Results AvailableHealthy AdultsDrug: SL TNX-102 at 2.4 mg|Drug: SL TNX-102 at 4.8 mg|Drug: SL TNX-102-A at 2.4 mg|Drug: Cyclobenzaprine tabletshttps://ClinicalTrials.gov/show/NCT01689259
6702867028Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's DiseaseActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: TRx0237 150 mg/day|Drug: TRx0237 250 mg/day|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01689246
6702967029Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's DiseaseActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: TRx0237 200 mg/day|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01689233
6703067030A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaCompletedNo Results AvailablePeripheral T-cell LymphomaDrug: SP-02L (darinaparsin for injection)|Drug: SP-02L (darinaparsin for injection)https://ClinicalTrials.gov/show/NCT01689220
6703167031To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)CompletedNo Results AvailableComplicated Infection|Bacterial InfectionsDrug: Avibactam (AVI)|Drug: Aztreonam (ATM)|Drug: combination of Aztreonam - Avibactam (ATM-AVI)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01689207
6703267032Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck CancerRecruitingNo Results AvailableLocally Advanced Head and Neck Squamous Cell CarcinomaDrug: genexolPM + cisplatinhttps://ClinicalTrials.gov/show/NCT01689194
6703367033Apathy in SchizophreniaRecruitingNo Results AvailableSchizophrenia|Apathyhttps://ClinicalTrials.gov/show/NCT01689181
6703467034Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking CessationTerminatedNo Results AvailableSmokingBehavioral: Counseling|Procedure: Chiropractic adjustmenthttps://ClinicalTrials.gov/show/NCT01689168
6703567035Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to ChildrenEnrolling by invitationNo Results AvailableMeningitis|Meningococcal InfectionBiological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugatehttps://ClinicalTrials.gov/show/NCT01689155
6703667036Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Insulin glargine new formulation (HOE901)|Drug: Insulin glargine (HOE901)https://ClinicalTrials.gov/show/NCT01689142
6703767037Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes MellitusCompletedNo Results AvailableType 1 Diabetes MellitusDrug: Insulin glargine new formulation (HOE901)|Drug: Insulin glargine (HOE901) (Lantus)https://ClinicalTrials.gov/show/NCT01689129
6703867038Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: Bardoxolone Methyl 20mg|Drug: Bardoxolone Methyl 80mg|Drug: Bardoxolone Methyl Placebo|Drug: Moxifloxacin 400mg|Drug: Moxifloxacin Placebohttps://ClinicalTrials.gov/show/NCT01689116
6703967039Therapeutic Alliances in Alcoholism TreatmentActive, not recruitingNo Results AvailableAlcohol Use DisordersBehavioral: Cognitive-behavioral treatment|Behavioral: Cognitive-behavioral treatmenthttps://ClinicalTrials.gov/show/NCT01689103
6704067040Diameter Changes of Retinal Vessels During HypoxiaRecruitingNo Results AvailableDiabetes Mellitus Type 1|Diabetic MaculopathyOther: COX inhibitor|Other: L-NG-monomethyl arginine citrate|Other: COX inhibitor + L-NG-monomethyl arginine citratehttps://ClinicalTrials.gov/show/NCT01689090
6704167041Time-differentiated Therapeutic HypothermiaRecruitingNo Results AvailableOut of Hospital Cardiac ArrestOther: Therapeutic hypothermiahttps://ClinicalTrials.gov/show/NCT01689077
6704267042Comparison of Surgical Approach to Endoscopic Pituitary Adenoma ResectionCompletedNo Results AvailablePituitary Adenoma|Posterior Septectomy|Stamm Approach|Quality of LifeProcedure: Stamm Approach|Procedure: Posterior Septectomyhttps://ClinicalTrials.gov/show/NCT01689064
6704367043Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes|Blod Pressure|Glucagon-like Peptide-1|Human Physiology|Blood FlowOther: human glucagon-like peptide 1 (7-36)amide|Other: human glucagon-like peptide 1 (9-36)amidehttps://ClinicalTrials.gov/show/NCT01689051
6704467044Brain Imaging Study of F17464CompletedNo Results AvailableHealthy VolunteersDrug: F17464https://ClinicalTrials.gov/show/NCT01689038
6704567045An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)TerminatedNo Results AvailableInflammation|Systemic Lupus ErythematosusDrug: NNC0114-0006|Drug: placebohttps://ClinicalTrials.gov/show/NCT01689025
6704667046The Effect of Facial Exercise on the Appearance of AgingCompletedNo Results AvailableAgingBehavioral: Facial Exercisehttps://ClinicalTrials.gov/show/NCT01689012
6704767047Cabozantinib for Advanced Urothelial CancerRecruitingNo Results AvailableUrothelial Carcinoma|Urethral Neoplasms|Ureteral Neoplasms|Urinary Bladder Neoplasms|Kidney NeoplasmsDrug: Cabozantinibhttps://ClinicalTrials.gov/show/NCT01688999
6704867048Environmental Polymorphisms Registry Health and Exposures SurveyEnrolling by invitationNo Results AvailableDiabetes|Heart Disease|Asthmahttps://ClinicalTrials.gov/show/NCT01688986
6704967049Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by SurgeryActive, not recruitingNo Results AvailableChildhood Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell CarcinomaDrug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Tivantinibhttps://ClinicalTrials.gov/show/NCT01688973
6705067050Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid MalignanciesCompletedNo Results AvailableSolid TumorsDrug: nesvacumab (REGN910/ SAR307746)|Drug: nesvacumab (REGN910/ SAR307746)|Drug: nesvacumab (REGN910/ SAR307746)|Drug: aflibercept (ziv-aflibercept)|Drug: aflibercept (ziv-aflibercept)https://ClinicalTrials.gov/show/NCT01688960

* Görseller ve İçerik tekif hakkına sahip olabilir